RVPG
CEMI

Relative Value Partners Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Relative Value Partners Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,991
Closed -$49K – 209
2021
Q1 		$49K Hold
13,991
– – ﹤0.01% 197
2020
Q4 		$66K Buy
+13,991
New +$72.3K 0.01% 199
2015
Q4 		– Sell
-13,991
Closed -$56K – 156
2015
Q3 		$56K Buy
+13,991
New +$63.3K 0.01% 132

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Relative Value Partners Group's CEMI Position: Q2 2021 in Review

Relative Value Partners Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 13,991 shares — an estimated $49K sold.

Relative Value Partners Group first reported a position in CEMI in Q3 2015 and held it in 3 quarters. The position peaked at $66K in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Relative Value Partners Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Relative Value Partners Group sold 13,991 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $49K.
  • Relative Value Partners Group first reported a position in Chembio diagnostics, Inc. in Q3 2015 and held it in 3 quarters.
  • Relative Value Partners Group's Chembio diagnostics, Inc. position peaked at $66K in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Relative Value Partners Group's 13F filing for Q2 2021, filed 12 Aug 2021.